PerfuseCell Cronus A/S: Financial statements 2017
CVR: 31606810
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 1,748,331 and a net result of DKK 308,579 compared with DKK 0 the year before. The profit margin was 17.6%. Equity in the 2017 report amounted to DKK 322,906. The solvency ratio was 46.8%.
- Revenue
- DKK 1,748,331
- Gross Profit
- DKK 309,716
- Profit/Loss
- DKK 308,579
- Equity
- DKK 322,906
- Total Assets
- DKK 690,374
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 1.7 mio. | 310 t. | 309 t. | 323 t. | - |
| 2016 | 0 | 0 | 0 | 14 t. | - |
| 2015 | 0 | 0 | -180 | 14 t. | - |
| 2014 | 0 | 0 | -3 t. | 15 t. | - |
| 2013 | 3 t. | 3 t. | -631 | 17 t. | - |
Official annual report
Keep an eye on PerfuseCell Cronus A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
On March 28, 2017, the company changed its name from PumpCell A/S to PerfuseCell A/S.
PerfuseCell Cronus A/S has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 0.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.